Importance and hurdles to drug discovery for neurological disease

Alzheimer disease in the United States (2010-2050) estimated using the 2010 census

(2013) L. E. Hebert et al.   NEUROLOGY

Unintended effects of orphan product designation for rare neurological diseases

(2012) Sinéad M. Murphy et al.   ANNALS OF NEUROLOGY

On being a neurologist in industry

(2012) David Leppert et al.   ANNALS OF NEUROLOGY

Review: Managing posttraumatic stress disorder in combat veterans with comorbid traumatic brain injury

(2012) Bruce Capehart et al.   JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT

Prevalence and Costs of Co-occurring Traumatic Brain Injury With and Without Psychiatric Disturbance and Pain Among Afghanistan and Iraq War Veteran VA Users

(2012) Brent C. Taylor et al.   MEDICAL CARE

Epidemiology of Autism Spectrum Disorders

(2012) Erin Duchan et al.   PEDIATRIC CLINICS OF NORTH AMERICA

Tourette syndrome: Evolving concepts

(2011) Joseph Jankovic et al.   MOVEMENT DISORDERS

Translational research: 4 ways to fix the clinical trial

(2011) Heidi Ledford   NATURE

The productivity crisis in pharmaceutical R&D

(2011) Fabio Pammolli et al.   NATURE REVIEWS DRUG DISCOVERY

Long-term Consequences of Repetitive Brain Trauma: Chronic Traumatic Encephalopathy

(2011) Robert A. Stern et al.   PM&R

Pharmaceutical Innovation in the 21st Century: New Drug Approvals in the First Decade, 2000–2009

(2010) K I Kaitin et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Is Pharma Running Out of Brainy Ideas?

(2010) G. Miller   SCIENCE

Financing of U.S. Biomedical Research and New Drug Approvals across Therapeutic Areas

(2009) E. Ray Dorsey et al.   PLoS One